CAV1 and Psoriasiform dermatitis: For example, decreased expression of Cav-1 is involved in pathogenesis of psoriasiform dermatitis in a murine model, and enhanced expression of Cav-1 through administration of a Cav-1 scaffolding domain peptide, which is a functional mimetic of Cav-1, provides substantial improvement of this skin condition [58].